Skip to main content
. 2009 Apr 15;113(25):6315–6321. doi: 10.1182/blood-2008-07-166694

Figure 2.

Figure 2

Probability of achieving a complete cytogenetic response versus developing an event for patients not in complete cytogenetic response. (A) After 3 months of imatinib therapy. (B) After 6 months of imatinib therapy. (C) After 12 months of imatinib therapy.